Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
Conditions: PDAC - Pancreatic Ductal Adenocarcinoma; FAP Intervention: Drug: [68Ga]FAPI-46 Sponsor: SOFIE Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer & Oncology | Carcinoma | Ductal Carcinoma | Pancreas | Pancreatic Cancer | Research | Study